Neurological Manifestations and Toxicities of the Antituberculosis Drugs (original) (raw)

• Abbott RJ, Currie S, Howe JG, Summer DW. Cerebrospinal fluid GABA in spasmodic torticollis. Annals of Neurology 13: 342, 1983
  PubMed CAS Google Scholar
• Acocella G, Bonollo L, Mainardi M, Margaroli P. Kinetic studies on rifampicin. III. Effect of phenobarbital on the half-life of the antibiotic. Tijdschrift voor Gastro-enterologie 17: 151–158, 1974
  CAS Google Scholar
• Adams HR. Neuromuscular blocking effect of aminoglycoside antibiotics in non-human primates. Journal of the American Veterinarian Association 163: 613–616, 1973
  CAS Google Scholar
• Ahmad I, Clark LA. Isoniazid hypersensitivity reaction involving the eyes: report of a case. Diseases of the Chest 52: 112–113, 1967
  PubMed CAS Google Scholar
• Allen BW, Ellard GA, Gammon PT, King RC, McDougall AC, et al. The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves. British Journal of Pharmacology 55: 151–155, 1975
  PubMed CAS Google Scholar
• Baciewicz AW, Self TH. Rifampicin drug interactions. Archives of Internal Medicine 144: 1667–1671, 1984
  PubMed CAS Google Scholar
• Baciewicz AW, Self TH. Isoniazid interactions. Southern Medical Journal 78: 714–718, 1985
  PubMed CAS Google Scholar
• Bear ES, Hoffman PF, Siegel SR, Randall RE. Suicidal ingestion of isoniazid: an uncommon cause of metabolic acidosis and seizures. Southern Medical Journal 69: 31–32, 1976
  PubMed CAS Google Scholar
• Benson WM, Stefko PL, Roe MD. Pharmacologic and toxicologic observations on hydrazine derivatives of isonicotinic acid. American Review of Tuberculosis 65: 376–391, 1952
  PubMed CAS Google Scholar
• Biehl JP, Vilter RW. Effect of isoniazid on vitamin B-6 metabolism; its possible significance in producing isoniazid neuritis. Proceedings of the Society of Experimental Biology and Medicine 85: 349–392, 1954
  Google Scholar
• Block SH. Carbamazepine-isoniazid interaction. Pediatrics 69: 494–495, 1982
  PubMed CAS Google Scholar
• Bolletti M, Croatto L. Deafness in a five year old girl resulting from streptomycin therapy during pregnancy. Acta Pediatrica Latina 11: 1–15, 1958
  Google Scholar
• Borman G, Calissendorf B. A case of irreversible bilateral optic damage after ethambutol therapy. Scandinavian Journal of Respiratory Disease 55: 176–180, 1974
  Google Scholar
• Boston Collaborative Drug Surveillance Program. Psychiatric side effects of nonpsychiatric drugs. Seminars in Psychiatry 3: 406–419, 1974
  Google Scholar
• Braham J. Isoniazid therapy for Huntington’s disease. Neurology 31: 1580–1581, 1981
  PubMed CAS Google Scholar
• Brazil OV, Corrando AP. The curariform action upon transmitter release and action. Journal of Pharmacology and Experimental Therapeutics 200: 576–587, 1957a
  Google Scholar
• Brazil OV, Corrando AP. The curariform action of streptomycin. Journal of Pharmacology and Experimental Therapeutics 120: 452–459, 1957b
  PubMed CAS Google Scholar
• Brazil OV, Prado-Franseschi J. The nature of neuromuscular block produced by neomycin and gentamycin. Archives of International Pharmacodynamics and Therapeutics 179: 78–85, 1969
  CAS Google Scholar
• Brown CV. Acute isoniazid poisoning. American Review of Respiratory Disease 105: 206–216, 1972
  PubMed CAS Google Scholar
• Brown CB, Ogg CS, Cameron JS, Bewick M. High dose furosemide in acute reversible intrinsic renal failure: a preliminary communication. Scottish Medical Journal 19 (Suppl): 35–39, 1974
  PubMed Google Scholar
• Bunn DA, Westlake RE. Toxicity of streptomycin in the human. In Waksman (Ed.) Streptomycin: nature and practical applications, pp.524–545, Bailliere, Tindall and Fox, London, 1949
• Bush GH. Prolonged neuromuscular block due to intraperitoneal streptomycin. British Medical Journal 1: 557–558, 1961
  PubMed CAS Google Scholar
• Centers for Disease Control. Tuberculosis — United States 1984. Morbidity and Mortality Weekly Report 34: 86–87, 1985
  Google Scholar
• Chang MJ, Escabedo M, Anderson DC, Hillman L, Feigin RD. Kanamycin and gentamycin treatment of neonatal sepsis and meningitis. Pediatrics 56: 695–699, 1975
  PubMed CAS Google Scholar
• Chinyanga HM, Stoyka WW. The effect of colymycin M, gentamycin and kanamycin on depression of neuromuscular transmission induced by pancuronium bromide. Canadian Anaesthetists Society Journal 21: 569–579, 1974
  PubMed CAS Google Scholar
• Citron KM. Ethambutol: a review with special reference to ocular toxicity. Tubercle 5 (Suppl.): 32–36, 1969
  Google Scholar
• Clark M, McCarthy CF. Electrolyte changes due to viomycin. Tubercle 54: 1317–1327, 1970
  Google Scholar
• Conway N, Birt BD. Streptomycin in pregnancy: effect on the foetal ear. British Medical Journal 2: 260–263, 1965
  PubMed CAS Google Scholar
• Coyer JR, Nicholson DP. Isoniazid induced convulsions: Part I — clinical and Part II — experimental. Southern Medical Journal 69: 294–297, 1976
  PubMed CAS Google Scholar
• Davidson S, Brish M, Rein N, Rubinstein M, Rubinstein E. Ototoxicity in premature infants treated with kanamycin. Pediatrics 66: 479–480, 1980
  PubMed CAS Google Scholar
• Dayal D, Shanto H. Some observations on the ototoxicity of thiacetazone. Indian Journal of Tuberculosis 17: 155–159, 1970
  Google Scholar
• Deka RC, Ghosh P, Kacker SK. Streptomycin ototoxicity: an audiologic and vestibular study. Ear, Nose and Throat Journal 56: 218–224, 1977
  CAS Google Scholar
• Devadatta S. Isoniazid-induced encephalopathy. Lancet 2: 440, 1965
  PubMed CAS Google Scholar
• Donald PR, Seilars SL. Streptomycin ototoxicity in the unborn child. South African Medical Journal 60: 316–318, 1981
  PubMed CAS Google Scholar
• Donomae I, Yamanato K. Clinical evaluation of ethambutol in pulmonary tuberculosis. Annals of the New York Academy of Science 135: 849–881, 1966
  CAS Google Scholar
• Dretchen KL, Gergis SD, Sokoll MD. Effect of various antibiotics on neuromuscular transmission. European Journal of Pharmacology 18: 201–203, 1972
  PubMed CAS Google Scholar
• Dretchen KL, Sokoll MD, Gergis SD. Relative effects of streptomycin on motor nerve terminal and end-plate. European Journal of Pharmacology 22: 10–16, 1973
  PubMed CAS Google Scholar
• Ducobu J, Dupont P, Laurent M, Bruat J. Acute isoniazid, ethambutol, rifampicin overdosage. Lancet 1: 632, 1982
  PubMed CAS Google Scholar
• Duquette P, Pleines J, duSouich P. Isoniazid for tremor in multiple sclerosis: a controlled trial. Neurology 35: 1772–1775, 1985
  PubMed CAS Google Scholar
• Echenwald HF. Some observations on dosage and toxicity of kanamycin in premature and full term infants. Annals of the New York Academy of Science 132: 984–990, 1966
  Google Scholar
• Elland GA. The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis. Tubercle 65: 211–227, 1984
  Google Scholar
• Emery ERJ. Neuromuscular blocking properties of antibiotics as a cause of post-operative apnoea. Anaesthesia 18: 57–65, 1983
  Google Scholar
• Engle J, Cruz ME, Shapiro B. Phenytoin encephalopathy. Lancet 2: 824–825, 1971
  Google Scholar
• Everett ED. Strausbaugh LJ. Antimicrobial agents and the CNS. Neurosurgery 6: 691–714, 1980
  CAS Google Scholar
• Eviatar L, Eviatar A. Development of head control and vestibular response in infants treated with aminoglycosides. Developmental Medicine and Child Neurology 24: 372–379, 1982
  PubMed CAS Google Scholar
• Fausti SA, Rappaport BZ, Schechter MA, Frey RH, Ward TT, et al. Detection of aminoglycoside ototoxicity by high frequency auditory evaluation. American Journal of Otolaryngology 5: 177–182, 1984
  PubMed CAS Google Scholar
• Finitzo-Hieber T, McCracken GH, Roeser RJ. Ototoxicity in neonates treated with gentamycin and kanamycin: results of a four year controlled follow up study. Pediatrics 63: 443–447, 1979
  PubMed CAS Google Scholar
• Fisk GC. Respiratory paralysis after a large dose of streptomycin: report of a case. British Medical Journal 1: 556–557, 1961
  PubMed CAS Google Scholar
• Francis DA, Grundy D, Heron JR. The response to isoniazid of action tremor in multiple sclerosis and its assessment using polarised light goniometry. Journal of Neurology, Neurosurgery and Psychiatry 49: 87–89, 1986
  CAS Google Scholar
• Friedman SA. Death following massive ingestion of isoniazid. American Review of Respiratory Disease 100: 859–862, 1969
  PubMed CAS Google Scholar
• Ganguin G, Rempt E. Streptomycin behandlung in der Schwangerschaft und ihre Auswirkung auf das Gehor des kinder. Zeitschrift fur Laryngologie, Rhinologie, Otologie und Ihre Grenzgebiete 49: 496–503, 1970
  PubMed CAS Google Scholar
• Garfield JW, Jones JM, Cohen NL, Daly JF, McClement JH. The auditory, vestibular and renal effects of capreomycin in humans. Annals of the New York Academy of Science 135: 1039–1046, 1966
  CAS Google Scholar
• Geiseler PJ, Manis RO, Maddux MS. Dosage of antituberculosis drugs in obese patients. American Review of Respiratory Disease 131: 944–946, 1985
  PubMed CAS Google Scholar
• Girgis NI, Yassin MW, Sippell JE, Sorenson K, Hassan A, et al. The value of ethambutol in the treatment of tuberculosis meningitis. American Review of Respiratory Disease 99: 14–17, 1976
  Google Scholar
• Girling DJ. Adverse effects of antituberculosis drugs. Drugs 23: 56–74, 1982
  PubMed CAS Google Scholar
• Goldman AL, Braman SS. Isoniazid: a review with emphasis on adverse effects. Chest 62: 71–77, 1972
  PubMed CAS Google Scholar
• Graham MD, Sataloff RT, Kemink JL. Titration of streptomycin therapy for bilateral Ménière’s disease: a preliminary report. Otolaryngology, Head and Neck Surgery 92: 440–447, 1984
  CAS Google Scholar
• Gupta SK, Hollingworth A, Alan J, William HO, Craig JW, et al. Toxic hazard from ‘1314’. British Medical Journal 1: 58, 1960
  Google Scholar
• Haas HL, Wieser HG. Effect of 1-cycloserine in cortical neurons in the rat. European Journal of Pharmacology 61: 79–83, 1980
  PubMed CAS Google Scholar
• Hallett M, Lindsey JW, Adelstein BD, Riley PO. Controlled trial of isoniazid therapy for severe postural cerebellar tremor in multiple sclerosis. Neurology 35: 1374–1377, 1985
  PubMed CAS Google Scholar
• Harada T, Satake S, Ichibawa H. Ocular toxicity with ethambutol. Japanese Journal of Clinical Opthalmology 23: 1345–1347, 1979
  Google Scholar
• Hokkanen E. The aggravating effect of some antibiotics on the neuromuscular blockade in myasthenia gravis. Acta Neurologica Scandinavica 40: 346–352, 1964
  PubMed CAS Google Scholar
• Holdiness MR. Chromatographic analysis of neurotransmitters and antitubercular drugs. PhD Dissertation, Emory University, Atlanta, 1981
• Holdiness MR. Chromatographic analysis of glutamic acid decarboxylase in biological samples. Journal of Chromatography Biomedical Applications 277: 1–24, 1983a
  PubMed CAS Google Scholar
• Holdiness MR. Mycobacterial diseases. Archives of Internal Medicine 143: 2333, 1983b
  PubMed CAS Google Scholar
• Holdiness MR. Clinical pharmacokinetics of the antituberculosis drugs. Clinical Pharmacokinetics 9: 511–544, 1984a
  PubMed CAS Google Scholar
• Holdiness MR. Mycobacterium colonization. Archives of Internal Medicine 144: 653–654, 1984b
  PubMed CAS Google Scholar
• Holdiness MR. Mycobacterium avium-intracellulare infection. Southern Medical Journal 77: 1614, 1984c
  PubMed CAS Google Scholar
• Holdiness MR. Cerebrospinal fluid pharmacokinetics of the antituberculosis drugs. Clinical Pharmacokinetics 10: 532–534, 1985a
  PubMed CAS Google Scholar
• Holdiness MR. Adverse cutaneous reactions to antituberculosis drugs. International Journal of Dermatology 24: 280–285, 1985b
  PubMed CAS Google Scholar
• Holdiness MR. Mycobacterium bovis infection. Archives of Internal Medicine 145: 1930, 1985d
  PubMed CAS Google Scholar
• Holdiness MR. Contact dermatitis to the antituberculosis drugs: a review. Contact Dermatitis 15, in press, 1987a
• Holdiness MR. Ethionamide. In Dollery (Ed.) Therapeutic drugs: a clinical pharmacopoeia, Churchill Livingstone, Edinburgh, in press, 1987b
• Holdiness MR. Thiacetazone. In Dollery (Ed.) Therapeutic drugs: a clinical pharmacopoeia, Churchill Livingstone, Edinburgh, in press, 1987c
• Howard JB, McCracken GH. Reappraisal of kanamycin usage in neonates. Journal of Pediatrics 86: 949–956, 1975
  PubMed CAS Google Scholar
• Howard JB, McCracken GH, Trijillo H, Mohs E. Amikacin in newborn infants: comparative pharmacology with kanamycin and clinical efficacy in 45 neonates with bacterial disease. Antimicrobial Agents and Chemotherapy 10: 205–210, 1976
  PubMed CAS Google Scholar
• Johnson AH, Hamilton CH. Kanamycin ototoxicity — possible potentiation by other drugs. Southern Medical Journal 63: 511–513, 1970
  PubMed CAS Google Scholar
• Johnson DAW. Drug-induced psychiatric disorders. Drugs 22: 57–69, 1981
  PubMed CAS Google Scholar
• Johnson J. Epanutin and isoniazid interactions. British Medical Journal 1: 152, 1975
  PubMed CAS Google Scholar
• Johnson J, Freeman L. Death due to isoniazid and phenytoin. British Medical Journal 129: 511, 1976
  CAS Google Scholar
• Johnson RN, Smith DH, Ritchie RT, Lockhart W. Prolonged streptomycin and isoniazid for pulmonary tuberculosis. British Medical Journal 1: 1679, 1964
  Google Scholar
• Joint IUAT/WHO Study Group. Tuberculosis control. Tubercle 63: 157, 1982
  Google Scholar
• Joshi VG. Isoniazid in the treatment of depressive syndrome: a pilot trial. Diseases of the Nervous System 38: 106–110, 1977
  Google Scholar
• Kanda T, Igarashi M. Ultrastructural changes in vestibular sensory end organs after viomycin sulfate intoxication. Acta Otolaryngology 68: 474–488, 1969
  CAS Google Scholar
• Karmon G, Savir H, Zevin D, Levi J. Bilateral optic neuropathy due to combined ethambutol and isoniazid treatment. Annals of Ophthalmology 11: 1013–1017, 1979
  PubMed CAS Google Scholar
• Karnik AM, Al-Shamali MA, French FF. A case of ocular toxicity to ethambutol: an idiosyncratic reaction. Postgraduate Medical Journal 61: 811–813, 1985
  PubMed CAS Google Scholar
• Kass I, Mandel W, Cohen H, Dressler SH. Isoniazid as a cause of optic neuritis and atrophy. Journal of the American Medical Association 164: 1740–1743, 1957
  PubMed CAS Google Scholar
• Kass I. Chemotherapy regimens used in the treatment of pulmonary tuberculosis. Observations on the efficacy of combination of ethambutol, capreomycin and companion drugs, including 4,4-diisoamyloxythiosemicarbanilide. Tubercle 46: 166, 1965
  CAS Google Scholar
• Kay L, Kampmann JP, Svendsen TL, Vergman B, Molholm JE, et al. Influence of rifampicin and isoniazid on the kinetics of phenytoin. British Journal of Clinical Pharmacology 20: 323–326, 1985
  PubMed CAS Google Scholar
• Keeping JA, Searle CWA. Optic neuritis following isoniazid therapy. Lancet 2: 278, 1955
  Google Scholar
• Korein J. Treatment questioned in familial spasmodic torticollis. Neurology 27: 899, 1977
  PubMed CAS Google Scholar
• Korein J, Kupersmith M. Reply. Annals of Neurology 13: 342, 1983
  Google Scholar
• Korein J, Lieberman A, Kupersmith M, Levidow L. Effect of L-glutamine and isoniazid on torticollis and segmental dystonia. Annals of Neurology 10: 247–250, 1981
  PubMed CAS Google Scholar
• Krauthammer C, Klerman GL. Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Archives of General Psychiatry 35: 1333–1339, 1978
  PubMed CAS Google Scholar
• Kutt H, Brennan R, Dehejia H. Diphenylhydantoin intoxication. American Review of Respiratory Diseases 101: 377–384, 1970
  CAS Google Scholar
• Kutt H, Penny JK. Usefulness of blood levels of antiepileptic drugs. Archives of Neurology 31: 283–288, 1974
  PubMed CAS Google Scholar
• Kutt H, Verebley K, McDowell F. Inhibition of diphenylhydantoin metabolism in rats and in rat liver microsomes by anti-tuberculosis drugs. Neurology 18: 706–710, 1968
  PubMed CAS Google Scholar
• Kutt H, Winters W, McDowell FH. Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapy. Neurology 16: 594–602, 1966
  PubMed CAS Google Scholar
• Lansdown FS, Beran M, Litwak T. Psychotoxic reaction during ethionamide therapy. American Review of Respiratory Disease 95: 1053–1055, 1967
  PubMed CAS Google Scholar
• Lederle Laboratories. Myambutol: guide to recognition and treatment of acute overdosage with Lederle products, 1976
• Lees AW. Ethionamide and isoniazid in previously untreated cases of pulmonary tuberculosis. Diseases of the Chest 45: 247–250, 1964
  PubMed CAS Google Scholar
• Leggat PO. Ethionamide neuropathy. Tubercle 43: 95–96, 1962
  PubMed CAS Google Scholar
• Leibold JE. The ocular toxicity of ethambutol and its relation to dose. Annals of the New York Academy of Science 135: 304–309, 1966
  Google Scholar
• Leroux ML. Existe-t-il une surdite congenital acquise due a la streptomycin? Annals of Otolaryngology 67: 194–196, 1950
  CAS Google Scholar
• Levanen J, Nordman R. Complete respiratory paralysis caused by a large dose of streptomycin and its treatment with calcium chloride. Annals of Clinical Research 75: 47–49, 1975
  Google Scholar
• Lewis WC, Calden G, Thurslan JR, Gibson WE. Psychiatric and neurological reaction to cycloserine in the treatment of tuberculosis. Diseases of the Chest 32: 172–177, 1957
  PubMed CAS Google Scholar
• L’Hommedieu C, Strough R, Brown L, Kettrick R, Polm R. Potentiation of neuromuscular weakness infant botulism by aminoglycosides. Journal of Pediatrics 95: 1065–1070, 1979
  PubMed Google Scholar
• Lichstein HC. Mechanism of competitive action of isonicotinic acid hydrazide and vitamin pyridoxine. Proceedings of the Society for Experimental Biology and Medicine 88: 519–522, 1955
  PubMed CAS Google Scholar
• Liggett SB, Berger JR, Hush J. Cerebrospinal fluid xanthochromia with rifampicin. Archives of Neurology 12: 282–283, 1982
  Google Scholar
• Line DH, Poole GW, Watersworth PM. Serum streptomycin levels and dizziness. Tubercle 51: 76–81, 1970
  PubMed CAS Google Scholar
• Lubinska L. Les troubles d’origine peripherique au cours de la narcose magnesienns. Archives of International Physiology 41: 456–473, 1935
  Google Scholar
• Mandell GL, Sande MA. Antimicrobial agents: drugs used in the chemotherapy of tuberculosis and leprosy. In Goodman AS, et al. (Eds.) The pharmacological basis of therapeutics, 6th ed., pp. 1200–1221, Macmillan, New York, 1980
  Google Scholar
• Manyan BV, Katz L, Hare TA, Kaniefski K, Tremblay RD. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington’s disease. Annals of Neurology 10: 35–37, 1981
  Google Scholar
• Manyan BV, Tremblay RD. Free and conjugated GABA in human cerebrospinal fluid: effect of degenerative neurological disease and isoniazid. Brain Research 307: 217–223, 1984
  Google Scholar
• Mattson RH, Lott IT, Fink AJ. Treatment of SSPE with inosiplex: a preliminary report. Archives of Neurology 32: 503, 1975
  Google Scholar
• McKenzie SA, Macnab AJ, Katz G. Neonatal pyridoxine responsive convulsions due to isoniazid therapy. Archives of Diseases of Children 51: 567–568, 1976
  CAS Google Scholar
• McLean DR. Failure of isoniazid therapy in Huntington’s disease. Neurology 32: 1189–1191, 1982
  PubMed CAS Google Scholar
• Meswesther WD, Mange RJ, Serpeck AA. Deafness following standard intravenous doses of ethacrynic acid. Journal of the American Medical Association 216: 795–798, 1971
  Google Scholar
• Miller AB, Fox W, Tall R. An international co-operative investigation into thiacetazone side effects. Tubercle 47: 33–40, 1966
  PubMed CAS Google Scholar
• Miller J, Robinson A, Percy AK. Acute isoniazid poisoning in childhood. American Journal of Diseases of Children 134: 290–292, 1980
  PubMed CAS Google Scholar
• Miller RR, Porter J, Greenblatt DJ. Clinical importance of the interaction of phenytoin and isoniazid. Chest 75: 356–358, 1979
  PubMed CAS Google Scholar
• Molgo J, Lemeignan M, Uchiyama T. Inhibitory effect of kanamycin on evoked transmitter release. European Journal of Pharmacology 2: 93–97, 1979
  Google Scholar
• Morales SM, Lincoln EM. The effect of isoniazid therapy on pyridoxine metabolism in children. American Review of Tuberculosis 75: 594–600, 1957
  PubMed CAS Google Scholar
• Morrow J, McDowell H, Ritchie C, Patterson V. Isoniazid and action tremor in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 48: 282–283, 1985
  CAS Google Scholar
• Murray FJ. Outbreak of unreported reactions among epileptics taking isoniazid. American Review of Respiratory Disease 86: 729–732, 1962
  PubMed CAS Google Scholar
• Nagami P, Yoshikawa TT. Aging and tuberculosis. Gerontology 30: 308–315, 1984
  PubMed CAS Google Scholar
• Narang RK. Acute psychotic reaction probably caused by ethionamide therapy. Tubercle 53: 137–138, 1972
  PubMed CAS Google Scholar
• Nelson LG. Grand mal seizures following observations of isoniazid. American Review of Respiratory Disease 91: 600–604, 1965
  PubMed CAS Google Scholar
• Newton RW. Side effects of drugs used to treat tuberculosis. Scottish Medical Journal 20: 47–49, 1975
  PubMed CAS Google Scholar
• Organick AB, Wilson EM. Multiple drugs in retreatment of chronic pulmonary tuberculosis. Diseases of the Chest 53: 183–193, 1968
  Google Scholar
• Paradilis AG, Triantaphyllidis C, Markomichelakis JM. The neuromuscular blocking activity of aminodeoxykanamycin as compared with most of other aminoglycoside antibiotics. Drug Research 27: 141–143, 1977
  Google Scholar
• Pearson CA. Thiacetazone toxicity in the treatment of tuberculosis patients in Nigeria. Journal of Tropical Medicine and Hygiene 81: 238–242, 1978
  PubMed CAS Google Scholar
• Perry TL, Hansen S. Sustained drug induced elevation of brain GABA in the rat. Journal of Neurochemistry 21: 1167–1175, 1973
  PubMed CAS Google Scholar
• Perry TL, MacLeod PM, Hansen S. Treatment of Huntington’s chorea with isoniazid. New England Journal of Medicine 297: 840, 1977
  PubMed CAS Google Scholar
• Perry TL, Urquhart N, Hansen S, Kennedy J. GABA drug-induced elevation in monkey brain. Journal of Neurochemistry 23: 443–445, 1974
  PubMed CAS Google Scholar
• Perry TL, Wall RA, Hansen S. Brain amino compounds in Huntington’s disease patients on isoniazid therapy. Neurology 35: 755–758, 1985
  PubMed CAS Google Scholar
• Perry TL, Wright JM, Hansen S, MacLeod PM. Isoniazid therapy of Huntington’s disease. Neurology 29: 370–375, 1985
  Google Scholar
• Pitts FW. Tuberculosis: prevention and therapy. In Hook et al. (Eds) Current concepts in infectious diseases, pp. 181–194, John Wiley & Sons, New York, 1977
  Google Scholar
• Poole GW, Schneeweiss J. Peripheral neuropathy due to ethionamide. American Review of Respiratory Disease 84: 890–892, 1961
  PubMed CAS Google Scholar
• Prazic M, Salaj B. Ototoxicity with children caused by streptomycin. Audiology 14: 173–176, 1975
  PubMed CAS Google Scholar
• Prado WA, Corrado AP, Marseillan RP. Competitive antagonism between calcium and antibiotics at the neuromuscular junction. Archives of International Pharmacodynamics and Therapeutics 231: 297–307, 1978
  CAS Google Scholar
• Pyle MM. Ethambutol and viomycin. Medical Clinics of North America 54: 1317–1327, 1970
  PubMed CAS Google Scholar
• Pyle MM, Pfeutze KH, Pearlson MD, de la Huerga J, Hubble RH. A 4 year clinical investigation of ethambutol in initial and retreatment cases of tuberculosis: efficiency, toxicity and bacterial resistance. American Review of Respiratory Disease 93: 428–441, 1966
  CAS Google Scholar
• Radner DB. Toxicologic and pharmacologic aspects of rifampicin. Chest 64: 212–216, 1973
  Google Scholar
• Rapport RL, Shaw CM. Phenytoin related cerebellar degeneration without seizures. Annals of Neurology 2: 437–439, 1977
  PubMed Google Scholar
• Reilly RH, Killman KF, Jenny EH, Marshal WH, Tausey T, et al. Convulsant effects of isoniazid. Journal of the American Medical Association 152: 1317–1321, 1953
  PubMed CAS Google Scholar
• Robertson WC, Clarke DB, Markesbery A. Review of 38 cases of subacute sclerosing panencephalitis: effect of amantadine on the natural course of the disease. Annals of Neurology 8: 422–425, 1980
  PubMed Google Scholar
• Robinson GC, Camborn KG. Hearing loss in infants of tuberculosis mothers treated with streptomycin during pregnancy. New England Journal of Medicine 271: 949–951, 1964
  PubMed CAS Google Scholar
• Rubin B, Burke JC. Further observations on the pharmacology of isoniazid. American Review of Tuberculosis 67: 644–651, 1953
  PubMed CAS Google Scholar
• Ruiz RC. D-Cycloserine in the treatment of pulmonary tuberculosis resistant to standard drugs. Diseases of the Chest 45: 181–184, 1964
  PubMed CAS Google Scholar
• Russo T, Tsalkos A. The toxicity of ethambutol on the human eye. Annals of Ophthalmology 2: 577–580, 1970
  Google Scholar
• Sakula A. Streptomycin and the foetus. British Journal of Tuberculosis 48: 69–72, 1954
  CAS Google Scholar
• Sandyk R. Phenytoin toxicity induced by antituberculosis drugs. South African Medical Journal 61: 382, 1982
  PubMed CAS Google Scholar
• Schaffeld HG, Garthwaite B, Amberson JR. Viomycin therapy in human tuberculosis. American Review of Tuberculosis 69: 520–525, 1954
  PubMed CAS Google Scholar
• Scharden JL. Drugs as teratogens, pp. 231, CRC Press, Inc., Cleveland, 1976
  Google Scholar
• Schmidt IG. CNS effects of ethambutol in monkeys. Annals of the New York Academy of Sciences 135: 759–774, 1966
  PubMed CAS Google Scholar
• Schmidt IG, Schmidt LH. Studies on the neurotoxicity of ethambutol and its racemate for the rhesus monkey. Journal of Neuropathology and Experimental Neurology 25: 40–67, 1966
  Google Scholar
• Senanyake N, Vyravanathan S, Kanacjasuriyam S. Cerebrovascular accident after a skipjack reaction in a patient taking isoniazid. British Medical Journal 2: 1127–1128, 1978
  Google Scholar
• Shepard TH. Catalog of teratogenic agents, pp. 111, 2nd ed., The Johns Hopkins University Press, Baltimore, 1976
  Google Scholar
• Sievers ML, Herrier RN. Treatment of acute isoniazid toxicity. American Journal of Hospital Pharmacy 32: 202–206, 1975
  PubMed CAS Google Scholar
• Silverstine H, Hyman SM, Feldbaum J, Silverstein D. Use of streptomycin sulfate in the treatment of Meniere’s disease. Otolarynology, Head and Neck Surgery 92: 229–232, 1984
  Google Scholar
• Singh YN, Harvey AL, Marshall IG. Antibiotic induced paralysis of the mouse phrenic nerve hemidiaphragm preparation and reversibility by calcium and neostigmine. Anaesthesiology 48: 418–424, 1978b
  CAS Google Scholar
• Singh YN, Marshall IG, Harvey AL. Some effects of the aminoglycoside antibiotic amikacin on neuromuscular and autonomic transmission. British Journal of Anaesthesiology 50: 109–117, 1978a
  CAS Google Scholar
• Smith CK, Durack DT. Isoniazid and reaction to cheese. Annals of Internal Medicine 88: 520–521, 1978
  PubMed CAS Google Scholar
• Snavely SR, Hodges GR. The neurotoxicity of antibacterial agents. Annals of Internal Medicine 101: 92–104, 1984
  PubMed CAS Google Scholar
• Sokoll MD, Diecke FPJ. Some effects of streptomycin on frog nerve in vitro. Archives Internationales de Pharmacodynamie et de Therapie 177: 332–339, 1978
  Google Scholar
• Sokoll MD, Gergis SD. Antibiotics and neuromuscular function. Anesthesiology 55: 148–159, 1981
  PubMed CAS Google Scholar
• Spittle BJ. Drug-induced psychotic syndromes. New Zealand Medical Journal 95: 349–352, 1982
  PubMed CAS Google Scholar
• Standaert FG, Riker WF. The consequences of cholinergic drug action on motor nerve terminals. Annals of the New York Academy of Sciences 144: 517–533, 1967
  CAS Google Scholar
• Starke H, Williams S. Acute poisoning from overdose of isoniazid: a case report. Lancet 83: 406–408, 1963
  CAS Google Scholar
• Sutton PH, Beattie A. Optic atrophy after administration of isoniazid with para-aminosalicylic acid. Lancet 1: 650–651, 1955
  Google Scholar
• Swash M, Roberst AH, Murnaghan A. Reversible pellagra-like encaphalopathy with ethionamide and cycloserine. Tubercle 53: 132–136, 1972
  PubMed CAS Google Scholar
• Swick HM. Rifampin ineffective in treating SSPE. New England Journal of Medicine 293: 405, 1975
  PubMed CAS Google Scholar
• Thulasimnay MT, Kela AK. Improvement of psychomotor epilepsy due to interaction of phenytoin-isoniazid. Tubercle 65: 229–230, 1984
  PubMed CAS Google Scholar
• Timmerman JE, Long JP, Pittinger GB. Neuromuscular blocking properties of various antibiotic agents. Toxicology and Applied Pharmacology 1: 299–304, 1959
  CAS Google Scholar
• Valsalan VC, Cooper GL. Carbamazepine intoxication caused by interactions with isoniazid. British Medical Journal 285: 261–262, 1982
  PubMed CAS Google Scholar
• Vanasin B, Colmer M, Davis PJ. Hypocalcemia, hypomagnesemia, and hypokalemia during chemotherapy of pulmonary tuberculosis. Chest 61: 496–498, 1972
  PubMed CAS Google Scholar
• van Wieringen A, Vrijlandt CM. Ethosuximide intoxication caused by interaction with isoniazid. Neurology 33: 1227–1228, 1983
  PubMed Google Scholar
• Vysniauskas CV, Hueckner HH. Severe reaction of the CNS following isoniazid therapy. American Review of Tuberculosis 69: 759–765, 1954
  PubMed CAS Google Scholar
• Wagner JC, Slama TG. Rifampicin-phenytoin drug interaction. (Abstract.) Drug Intelligence and Clinical Pharmacy 18: 497, 1984
  Google Scholar
• Walby AP, Kerr AG. Streptomycin sulphate and deafness: a review of the literature. Clinical Otolaryngology 7: 63–68, 1982
  PubMed CAS Google Scholar
• Walker WC, Murdock JM. Cycloserine in the treatment of pulmonary tuberculosis. Tubercle 38: 297–300, 1957
  PubMed CAS Google Scholar
• Warkany J. Antituberculosis drugs. Teratology 20: 133–138, 1979
  PubMed CAS Google Scholar
• Watson EH, Stow RM. Streptomycin therapy — effects on fetus. Journal of the American Medical Association 137: 1599–1600, 1948
  PubMed CAS Google Scholar
• Weinstein L, Goldfield M, Adamis D. A study of intrathecal chemotherapy in bacterial meningitis. Medical Clinics of North American 37: 1363–1378, 1953
  Google Scholar
• Werner CA, Tompsett R, Muschenheim E. The toxicity of viomycin in humans. American Review of Tuberculosis 63: 49–59, 1951
  PubMed CAS Google Scholar
• Wood ER. Isoniazid toxicity: pyridoxine controlled seizures in a dialysis patient. Journal of the Kansas Medical Society 12: 551–552, 1981
  Google Scholar
• Woods JD, Peesker SJ. Gorecki DKJ, Tsui D. Effect of L-cycloserine on brain GABA metabolism. Canadian Journal of Physiology and Pharmacology 56: 62–68, 1978
  Google Scholar
• Wright J, Stokes EF, Sweeny VP. Isoniazid induced carbamazepine toxicity and vice versa: a double blind drug interaction. New England Journal of Medicine 307: 1325–1327, 1982
  PubMed CAS Google Scholar
• Yamamoto M, Otsuki S, Kuroda H, Ogawa N. Isoniazid effects on choreiform movement and on GABA, HVA and 5-HIAA in CSF. Acta Neurologica Scandinavica 67: 124–127, 1983
  PubMed CAS Google Scholar
• Yiannikas C, Walsh J, McLeod JG. Visual evoked potentials in the detection of subclinical optic toxic effects secondary to ethambutol. Archives of Neurology 40: 645–648, 1983
  PubMed CAS Google Scholar